While serum TNF-α levels are widely recognized as biomarkers for inflammation and strongly correlate with the severity of inflammatory responses and the presence of autoimmunity49–51, it is important to consider that local TNF-α concentrations in the tumor microenvironment may be significantly higher than what is reflected by serum levels. The gene discussed is TNF; the disease is neoplasm.